{"registry_intelligence":{"schema_version":"alpha-registry-intelligence-v1","record_version":"unavailable","subject":"alpha:company:definium-therapeutics-inc","as_of":"unavailable","recorded_at":"unavailable","availability":"unavailable","records":[],"next_offset":null,"limitations":["Structured intelligence is not currently available. Existing published profile evidence remains accessible."]},"protocol_version":"0.1","schema_version":"alpha.governance.entity.public.v1","record_version":"public-1","entity":{"id":"alpha:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9","type":"Company","slug":"definium-therapeutics-inc","canonical_url":"https://registry.alpha.ac/companies/definium-therapeutics-inc","legal_name":"Definium Therapeutics, Inc.","display_name":"Definium Therapeutics, Inc.","aliases":[]},"publication":{"state":"PUBLISHED","published_at":"2026-09-29T04:45:56.31437+00:00","observed_at":"2026-09-29T04:45:56.31437+00:00","reviewed_at":"2026-09-29T04:45:56.31437+00:00","verified_at":"2026-09-29T04:45:56.31437+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":20,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"representations":{"html":{"href":"https://registry.alpha.ac/companies/definium-therapeutics-inc","media_type":"text/html"},"markdown":{"href":"https://registry.alpha.ac/companies/definium-therapeutics-inc.md","media_type":"text/markdown"},"json":{"href":"https://registry.alpha.ac/api/public/companies/definium-therapeutics-inc?format=record","media_type":"application/json"},"jsonld":{"href":"https://registry.alpha.ac/api/public/companies/definium-therapeutics-inc?format=jsonld","media_type":"application/ld+json"},"api":{"href":"https://registry.alpha.ac/api/public/companies/definium-therapeutics-inc","media_type":"application/json"},"mcp":{"uri":"alpha://companies/definium-therapeutics-inc","endpoint":"https://mcp.alpha.ac/mcp","media_type":"application/json"}},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":20,"under_review_claim_count":1,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":2,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":20,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":20,"corroborated_claims":0,"sources":3,"distinct_sources":2,"role_claims":0,"last_reviewed_at":"2026-09-29T04:45:56.31437+00:00","observed_at":"2026-09-29T04:45:56.31437+00:00","freshness_days":0}},"claims":[{"id":"alpha:claim:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:legal_name:1","subject_id":"alpha:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9","predicate":"schema:legalName","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Definium Therapeutics, Inc.","claim_type":"legal_name","predicate_id":"alpha:predicate:legal_name","predicate_version":1,"machine_key":"legal_name","human_label":"Legal Name","governed_predicate":true,"machine_value":"Definium Therapeutics, Inc.","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-29T04:45:56.31437+00:00","sources":[{"id":"alpha:evidence:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:1","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/definium-therapeutics-inc","source_date":null,"retrieved_at":"2026-09-29T04:45:56.31437+00:00","locator":null}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-09-29T04:45:56.31437+00:00","reviewed_at":"2026-09-29T04:45:56.31437+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:entity_status:3","subject_id":"alpha:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9","predicate":"alpha:entityStatus","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Public listing published","claim_type":"entity_status","predicate_id":"alpha:predicate:entity_status","predicate_version":1,"machine_key":"entity_status","human_label":"Entity Status","governed_predicate":true,"machine_value":"Public listing published","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-29T04:45:56.31437+00:00","sources":[{"id":"alpha:evidence:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:1","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/definium-therapeutics-inc","source_date":null,"retrieved_at":"2026-09-29T04:45:56.31437+00:00","locator":null}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-09-29T04:45:56.31437+00:00","reviewed_at":"2026-09-29T04:45:56.31437+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:published_fact:4","subject_id":"alpha:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9","predicate":"alpha:country","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"US","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"US","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-29T04:45:56.31437+00:00","sources":[{"id":"alpha:evidence:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:1","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/definium-therapeutics-inc","source_date":null,"retrieved_at":"2026-09-29T04:45:56.31437+00:00","locator":null}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-09-29T04:45:56.31437+00:00","reviewed_at":"2026-09-29T04:45:56.31437+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:published_fact:5","subject_id":"alpha:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9","predicate":"alpha:sector","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Healthcare","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"Healthcare","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-29T04:45:56.31437+00:00","sources":[{"id":"alpha:evidence:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:1","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/definium-therapeutics-inc","source_date":null,"retrieved_at":"2026-09-29T04:45:56.31437+00:00","locator":null}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-09-29T04:45:56.31437+00:00","reviewed_at":"2026-09-29T04:45:56.31437+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:published_fact:6","subject_id":"alpha:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9","predicate":"alpha:industry","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Biotechnology","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"Biotechnology","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-29T04:45:56.31437+00:00","sources":[{"id":"alpha:evidence:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:1","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/definium-therapeutics-inc","source_date":null,"retrieved_at":"2026-09-29T04:45:56.31437+00:00","locator":null}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-09-29T04:45:56.31437+00:00","reviewed_at":"2026-09-29T04:45:56.31437+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:leadership_role:7","subject_id":"alpha:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:carol-a-vallone-dftx","object_label":null,"object_source_name_forms":[],"value":"Carol A. Vallone: Chair of the Board","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Carol A. Vallone: Chair of the Board","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-29T04:45:56.31437+00:00","sources":[{"id":"alpha:evidence:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-182034","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000119312526182034/dftx-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-06T05:19:31.871297+00:00","locator":null}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-29T04:45:56.31437+00:00","reviewed_at":"2026-09-29T04:45:56.31437+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:leadership_role:8","subject_id":"alpha:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:andreas-krebs-dftx","object_label":null,"object_source_name_forms":[],"value":"Andreas Krebs: Vice Chair of the Board","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Andreas Krebs: Vice Chair of the Board","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-29T04:45:56.31437+00:00","sources":[{"id":"alpha:evidence:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-182034","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000119312526182034/dftx-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-06T05:19:31.871297+00:00","locator":null}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-29T04:45:56.31437+00:00","reviewed_at":"2026-09-29T04:45:56.31437+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:leadership_role:9","subject_id":"alpha:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:david-gryska-definium-therapeutics-inc","object_label":null,"object_source_name_forms":[],"value":"David Gryska: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"David Gryska: Director","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-29T04:45:56.31437+00:00","sources":[{"id":"alpha:evidence:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-182034","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000119312526182034/dftx-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-06T05:19:31.871297+00:00","locator":null}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-29T04:45:56.31437+00:00","reviewed_at":"2026-09-29T04:45:56.31437+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:leadership_role:10","subject_id":"alpha:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:david-gryska-north-carolina-dftx","object_label":null,"object_source_name_forms":[],"value":"David Gryska North Carolina: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"David Gryska North Carolina: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-27","valid_to":null,"recorded_at":"2026-09-29T04:45:56.31437+00:00","sources":[{"id":"alpha:evidence:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:3","source_type":"sec_proxy","title":"DEF 14A dftx-20260427.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000119312526182034/dftx-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-02T00:22:53.01225+00:00","locator":null}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2026-04-27","effective_until":null,"observed_at":"2026-09-29T04:45:56.31437+00:00","reviewed_at":"2026-09-29T04:45:56.31437+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:leadership_role:11","subject_id":"alpha:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:matthew-t-wiley-dftx","object_label":null,"object_source_name_forms":[],"value":"Matthew T. Wiley: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Matthew T. Wiley: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-09-29T04:45:56.31437+00:00","sources":[{"id":"alpha:evidence:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:3","source_type":"sec_proxy","title":"DEF 14A dftx-20260427.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000119312526182034/dftx-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-02T00:22:53.01225+00:00","locator":null}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-09-29T04:45:56.31437+00:00","reviewed_at":"2026-09-29T04:45:56.31437+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:leadership_role:12","subject_id":"alpha:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:robert-barrow-dftx","object_label":null,"object_source_name_forms":[],"value":"Robert Barrow: Chief Executive Officer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Robert Barrow: Chief Executive Officer and Director","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-29T04:45:56.31437+00:00","sources":[{"id":"alpha:evidence:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-182034","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000119312526182034/dftx-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-06T05:19:31.871297+00:00","locator":null}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-29T04:45:56.31437+00:00","reviewed_at":"2026-09-29T04:45:56.31437+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:leadership_role:13","subject_id":"alpha:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:roger-adsett","object_label":null,"object_source_name_forms":[],"value":"Roger Adsett: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Roger Adsett: Director","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-29T04:45:56.31437+00:00","sources":[{"id":"alpha:evidence:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-182034","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000119312526182034/dftx-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-06T05:19:31.871297+00:00","locator":null}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-29T04:45:56.31437+00:00","reviewed_at":"2026-09-29T04:45:56.31437+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:leadership_role:14","subject_id":"alpha:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:roger-adsett-pennsylvania-dftx","object_label":null,"object_source_name_forms":[],"value":"Roger Adsett Pennsylvania: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Roger Adsett Pennsylvania: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-27","valid_to":null,"recorded_at":"2026-09-29T04:45:56.31437+00:00","sources":[{"id":"alpha:evidence:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:3","source_type":"sec_proxy","title":"DEF 14A dftx-20260427.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000119312526182034/dftx-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-02T00:22:53.01225+00:00","locator":null}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2026-04-27","effective_until":null,"observed_at":"2026-09-29T04:45:56.31437+00:00","reviewed_at":"2026-09-29T04:45:56.31437+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:leadership_role:15","subject_id":"alpha:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:roger-crystal","object_label":null,"object_source_name_forms":[],"value":"Roger Crystal: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Roger Crystal: Director","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-29T04:45:56.31437+00:00","sources":[{"id":"alpha:evidence:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-182034","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000119312526182034/dftx-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-06T05:19:31.871297+00:00","locator":null}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-29T04:45:56.31437+00:00","reviewed_at":"2026-09-29T04:45:56.31437+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:leadership_role:16","subject_id":"alpha:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:suzanne-bruhn","object_label":null,"object_source_name_forms":[],"value":"Suzanne Bruhn: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Suzanne Bruhn: Director","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-29T04:45:56.31437+00:00","sources":[{"id":"alpha:evidence:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-182034","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000119312526182034/dftx-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-06T05:19:31.871297+00:00","locator":null}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-29T04:45:56.31437+00:00","reviewed_at":"2026-09-29T04:45:56.31437+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:leadership_role:17","subject_id":"alpha:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:brandi-l-roberts","object_label":null,"object_source_name_forms":[],"value":"Brandi L. Roberts: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Brandi L. Roberts: Chief Financial Officer","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-29T04:45:56.31437+00:00","sources":[{"id":"alpha:evidence:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-182034","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000119312526182034/dftx-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-06T05:19:31.871297+00:00","locator":null}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-29T04:45:56.31437+00:00","reviewed_at":"2026-09-29T04:45:56.31437+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:leadership_role:18","subject_id":"alpha:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:daniel-karlin","object_label":null,"object_source_name_forms":[],"value":"Daniel Karlin: Chief Medical Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Daniel Karlin: Chief Medical Officer","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-29T04:45:56.31437+00:00","sources":[{"id":"alpha:evidence:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-182034","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000119312526182034/dftx-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-06T05:19:31.871297+00:00","locator":null}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-29T04:45:56.31437+00:00","reviewed_at":"2026-09-29T04:45:56.31437+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:leadership_role:19","subject_id":"alpha:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:mark-r-sullivan","object_label":null,"object_source_name_forms":[],"value":"Mark R. Sullivan: Chief Legal Officer and Corporate Secretary","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Mark R. Sullivan: Chief Legal Officer and Corporate Secretary","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-29T04:45:56.31437+00:00","sources":[{"id":"alpha:evidence:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-182034","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000119312526182034/dftx-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-06T05:19:31.871297+00:00","locator":null}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-29T04:45:56.31437+00:00","reviewed_at":"2026-09-29T04:45:56.31437+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:leadership_role:20","subject_id":"alpha:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:matthew-t-wiley-dftx","object_label":null,"object_source_name_forms":[],"value":"Matthew T. Wiley: Chief Commercial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Matthew T. Wiley: Chief Commercial Officer","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-29T04:45:56.31437+00:00","sources":[{"id":"alpha:evidence:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-182034","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000119312526182034/dftx-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-06T05:19:31.871297+00:00","locator":null}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-29T04:45:56.31437+00:00","reviewed_at":"2026-09-29T04:45:56.31437+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:leadership_role:21","subject_id":"alpha:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:robert-barrow-dftx","object_label":null,"object_source_name_forms":[],"value":"Robert Barrow: Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Robert Barrow: Chief Executive Officer","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-29T04:45:56.31437+00:00","sources":[{"id":"alpha:evidence:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-182034","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000119312526182034/dftx-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-06T05:19:31.871297+00:00","locator":null}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-29T04:45:56.31437+00:00","reviewed_at":"2026-09-29T04:45:56.31437+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"}],"evidence":[{"id":"alpha:evidence:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:1","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/definium-therapeutics-inc","source_date":null,"retrieved_at":"2026-09-29T04:45:56.31437+00:00","locator":null},{"id":"alpha:evidence:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-182034","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000119312526182034/dftx-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-06T05:19:31.871297+00:00","locator":null},{"id":"alpha:evidence:company:985d4ad0-a405-41ec-8ed8-2b8c1c2a17d9:3","source_type":"sec_proxy","title":"DEF 14A dftx-20260427.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000119312526182034/dftx-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-02T00:22:53.01225+00:00","locator":null}],"coverage":{"identity":"PUBLISHED","business":"PUBLISHED","leadership":"PUBLISHED","board_and_committees":"PUBLISHED","governance":"NOT_ASSERTED","financials":"NOT_ASSERTED","workforce":"NOT_ASSERTED","ownership":"NOT_ASSERTED","ratings":"NOT_PUBLISHED","market_and_index_context":"PUBLISHED"},"representation_version":"alpha-governance-record-v2","role_modules":[],"attention":[],"committee_data":[]}